http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014107201-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b09f893b262cefd50c5e76c4b85d1c0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f173386ff485cc27cf28933aca2b09e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c257f73e67806f3d96a5481c53adff90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc321bc6792ed092538b544205f4762a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c05a0f11948c64222377e57ab3780a88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbf7c315ca05388aeadf6dba00e69ff8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205
filingDate 2012-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99a626f9b6e0d1c39a110f9cab656b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d5f513a1824d10cf2dea7f83cda068a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208aefcc1c1e68b1d669dd64ca6c6c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1e845f64c2b1b6df088114ad8dde789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44894483eb19be138e95c2d70215496d
publicationDate 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2014107201-A1
titleOfInvention Use of L-Carnitine, Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function
abstract The invention relates to the use of L-carnitine, a salt of L-carnitine, a derivative of L-carnitine and/or salt of a derivative of L-carnitine, as well as respective methods and compositions, for reducing or preventing fatigue and/or for improving cognitive function in an animal. The animal is preferably a healthy individual and the use is preferably a non-therapeutic use.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10330685-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015168100-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012221895-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018039297-A1
priorityDate 2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007281010-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5073376-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128916092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107739
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127955030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129112797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54271604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129359091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129142604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127401709

Total number of triples: 42.